Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.25 GBX | -9.76% | -31.48% | -57.95% |
Apr. 19 | Redx Pharma shareholders approve AIM delisting plans | AN |
Apr. 19 | Redx Pharma Gets Shareholder Approval for Delisting from AIM | MT |
Sales 2024 * | 12.5M 15.58M | Sales 2025 * | - | Capitalization | 35.98M 44.84M |
---|---|---|---|---|---|
Net income 2024 * | -26M -32.4M | Net income 2025 * | -49M -61.07M | EV / Sales 2024 * | 2.49 x |
Net cash position 2024 * | 4.81M 5.99M | Net Debt 2025 * | 39.12M 48.75M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.38
x | P/E ratio 2025 * |
-0.73
x | Employees | 101 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.72% |
Latest transcript on Redx Pharma Plc
1 day | -9.76% | ||
1 week | -15.91% | ||
Current month | -50.00% | ||
1 month | -52.56% | ||
3 months | -54.88% | ||
6 months | -64.42% | ||
Current year | -57.95% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Anson
CEO | Chief Executive Officer | - | 18-05-31 |
Peter J. Collum
DFI | Director of Finance/CFO | - | 21-05-04 |
Chief Operating Officer | 46 | 18-11-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 22-01-26 |
Joseph Anderson
BRD | Director/Board Member | 65 | 23-09-05 |
Peter Presland
BRD | Director/Board Member | 75 | 17-11-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 9.25 | -9.76% | 164,204 |
24-04-23 | 10.25 | -16.33% | 277,553 |
24-04-22 | 12.25 | +2.08% | 265,344 |
24-04-19 | 12 | -5.88% | 582,013 |
24-04-18 | 12.75 | -5.56% | 839,827 |
Delayed Quote London S.E., April 24, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-57.95% | 49.6M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- REDX Stock